PSP Research LLC 13F 持仓 · 2026年Q2
PSP Research 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 75 只证券，申报市值合计 1.88 亿美元。前几大持仓：XBI（48.01%）、SGOV（37.51%）、RPRX（0.33%）。本季前 25 大持仓中：增持 1 只、减持 9 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | XBI | SPDR SERIES TRUST | $90.2M | 48.01% | 570,000 | 增持 |
| 2 | SGOV | ISHARES TR | $70.5M | 37.51% | 700,000 | 持平 |
| 3 | RPRX | ROYALTY PHARMA PLC | $616,770 | 0.33% | 11,000 | 持平 |
| 4 | ARGX | ARGENX SE | $594,701 | 0.32% | 641 | 持平 |
| 5 | INCY | INCYTE CORP | $600,808 | 0.32% | 5,300 | 持平 |
| 6 | NRIX | NURIX THERAPEUTICS INC | $606,500 | 0.32% | 25,000 | 减持 |
| 7 | IRON | DISC MEDICINE INC | $585,120 | 0.31% | 8,000 | 持平 |
| 8 | RAPP | RAPPORT THERAPEUTICS INC | $583,380 | 0.31% | 14,000 | 持平 |
| 9 | GLUE | MONTE ROSA THERAPEUTICS INC | $556,600 | 0.30% | 23,000 | 减持 |
| 10 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $567,630 | 0.30% | 17,000 | 减持 |
| 11 | TRVI | TREVI THERAPEUTICS INC | $559,500 | 0.30% | 30,000 | 持平 |
| 12 | HALO | HALOZYME THERAPEUTICS INC | $547,890 | 0.29% | 7,000 | 减持 |
| 13 | IONS | IONIS PHARMACEUTICALS INC | $539,172 | 0.29% | 6,800 | 持平 |
| 14 | TGTX | TG THERAPEUTICS INC | $549,400 | 0.29% | 10,000 | 减持 |
| 15 | PHVS | PHARVARIS N V | $518,700 | 0.28% | 15,000 | 减持 |
| 16 | ACAD | ACADIA PHARMACEUTICALS INC | $500,080 | 0.27% | 19,766 | 持平 |
| 17 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $516,534 | 0.27% | 19,700 | 持平 |
| 18 | AUPH | AURINIA PHARMACEUTICALS INC | $509,100 | 0.27% | 30,000 | 持平 |
| 19 | IMVT | IMMUNOVANT INC | $500,890 | 0.27% | 13,000 | 减持 |
| 20 | NBIX | NEUROCRINE BIOSCIENCES INC | $505,605 | 0.27% | 3,000 | 减持 |
| 21 | CLDX | CELLDEX THERAPEUTICS INC NEW | $483,730 | 0.26% | 13,000 | 持平 |
| 22 | IMCR | IMMUNOCORE HLDGS PLC | $480,727 | 0.26% | 15,141 | 持平 |
| 23 | PTCT | PTC THERAPEUTICS INC | $489,420 | 0.26% | 6,000 | 持平 |
| 24 | COGT | COGENT BIOSCIENCES INC | $464,400 | 0.25% | 12,000 | 持平 |
| 25 | DFTX | DEFINIUM THERAPEUTICS INC | $470,400 | 0.25% | 10,000 | 减持 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR